Personalized management of acenocoumarol dosage using eGFR: Analysis of INR data in a cohort of 204 patients
Renal function, as measured by BSA-adjusted eGFR, is a critical determinant of acenocoumarol dose requirements. These findings support the inclusion of renal function in future acenocoumarol dose calculators and emphasize the importance of individualized dosing strategies.
Authors
- Dzhem Farandzha (ORCID: https://orcid.org/0000-0003-2011-354X)
- Dobri Hazarbasanov (ORCID: https://orcid.org/0000-0002-5589-0835)
- Vasil Velchev (ORCID: https://orcid.org/0009-0008-2550-835X)
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2025-10-09
- DOI
- https://doi.org/10.5414/cp204882
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00